Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Spinelli

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care TestMonica Gandhi, Peter Bacchetti, Matthew A Spinelli, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIVMatthew S Durstenfeld, Michael J Peluso, Matthew A Spinelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2021
Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus ProtectionRandy M Stalter, Jared M Baeten, Deborah Donnell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2024
High Retention and Adherence With Rapid Long-acting Injectable Preexposure Prophylaxis Implementation in an Urban Safety Net Clinic PopulationMatthew A Spinelli, Ezra Bisom-Rapp, Megan J Heise, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 17, 2019
Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence TestingMatthew A Spinelli, David V Glidden, Peter L Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2020
Brief Report: High Accuracy of a Real-Time Urine Antibody-Based Tenofovir Point-of-Care Test Compared With Laboratory-Based ELISA in Diverse PopulationsMatthew A Spinelli, Warren C Rodrigues, Guohong Wang, et al.
Open Forum Infectious Diseases|July 21, 2021
Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care TestingKelly A Johnson, Xin Niu, David V Glidden, et al.
AIDS Research and Human Retroviruses|May 24, 2019
Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration ProjectMatthew A Spinelli, David V Glidden, Peter L Anderson, et al.
AIDS (London, England)|March 7, 2025
High viral suppression amid demographic disparities: a US national cohort of people with HIV on a popular dating appHannah R Schmidt, Megan J Heise, Kevin Sassaman, et al.
AIDS (London, England)|March 31, 2025
Interest and disparities in awareness and uptake of doxyPEP among U.S. MSM living with HIVTyler Martinson, Megan J Heise, Kevin Sassaman, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care TestMonica Gandhi, Peter Bacchetti, Matthew A Spinelli, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIVMatthew S Durstenfeld, Michael J Peluso, Matthew A Spinelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2021
Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus ProtectionRandy M Stalter, Jared M Baeten, Deborah Donnell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2024
High Retention and Adherence With Rapid Long-acting Injectable Preexposure Prophylaxis Implementation in an Urban Safety Net Clinic PopulationMatthew A Spinelli, Ezra Bisom-Rapp, Megan J Heise, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 17, 2019
Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence TestingMatthew A Spinelli, David V Glidden, Peter L Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2020
Brief Report: High Accuracy of a Real-Time Urine Antibody-Based Tenofovir Point-of-Care Test Compared With Laboratory-Based ELISA in Diverse PopulationsMatthew A Spinelli, Warren C Rodrigues, Guohong Wang, et al.
Open Forum Infectious Diseases|July 21, 2021
Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care TestingKelly A Johnson, Xin Niu, David V Glidden, et al.
AIDS Research and Human Retroviruses|May 24, 2019
Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration ProjectMatthew A Spinelli, David V Glidden, Peter L Anderson, et al.
AIDS (London, England)|March 7, 2025
High viral suppression amid demographic disparities: a US national cohort of people with HIV on a popular dating appHannah R Schmidt, Megan J Heise, Kevin Sassaman, et al.
AIDS (London, England)|March 31, 2025
Interest and disparities in awareness and uptake of doxyPEP among U.S. MSM living with HIVTyler Martinson, Megan J Heise, Kevin Sassaman, et al.
Pageof 8